Search for Clinical Trial Results

Sponsored By

Polycystic Kidney, Autosomal Dominant - 9 Studies Found

Status Study
Completed Study Name: Bosutinib For Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Date: 2010-10-28
Interventions:
  • Drug: Bosutinib Once daily ora
Completed Study Name: Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Date: 2007-03-12
Interventions:
  • Drug: pravastatin Pravastatin

Active, not recruiting Study Name: A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Date: 2012-03-09
Interventions: Drug: KD019 (tesevatinib) Other Name: XL647
Completed Study Name: The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Date: 2006-12-10
Interventions:
  • Behavioral: High Sodium Diet 2
Completed Study Name: Feasibility Study of Metformin Therapy in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Date: 2016-09-13
Interventions:
  • Drug: Metformin Monitoring of

Completed Study Name: Tolvaptan Open-Label Pilot Efficacy, Tolerability and Safety Study in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Date: 2006-12-18
Interventions:
  • Drug: tolvaptan 45 mg tablet i
Completed Study Name: Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Condition:
  • Chronic Kidney Disease
  • Polycystic Kidney, Autosomal Dominant Date: 2010-04-26
Completed Study Name: Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Date: 2011-07-29
Completed Study Name: A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]
Condition: Autosomal Dominant Polycystic Kidney Disease （ADPKD)
Date: 2010-12-06
Interventions: Drug: tolvaptan Repeated oral administration twice daily (morning and evening) at one of three split dos